Expand ARE Menu
ARE MENU

ARE Latest Press Releases

-- April 2, 2024 --

Alexandria Real Estate Equities, Inc. Named One of the Most Trustworthy Companies in America by Newsweek for Second Consecutive Year PRNewswire 8:30 AM

-- April 1, 2024 --

Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal With insitro for a 6-Year Lease Extension at the Alexandria Center for Advanced Technologies Mega Campus in South San Francisco PRNewswire 8:30 AM

-- March 4, 2024 --

Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 1Q24, for an Aggregate of $5.02 per Common Share for the 12 Months Ending March 31, 2024, an Increase of 24 Cents, or 5 Percent, Over the 12 Months Ended March 31, 2023 PRNewswire 4:10 PM
Alexandria Real Estate Equities, Inc. Announces Significant Early Renewal and 10-Year Lease Extension With Longstanding Credit Tenant Takeda at the Alexandria Center at Kendall Square Mega Campus in Cambridge PRNewswire 7:00 AM

-- February 28, 2024 --

Alexandria Real Estate Equities, Inc. to Hold Its First Quarter 2024 Operating and Financial Results Conference Call and Webcast on April 23, 2024 PRNewswire 8:30 AM

-- February 27, 2024 --

Alexandria Real Estate Equities, Inc. Continues Its Distinctive, Steadfast and Positive Impact on the Widespread and Complex Mental Health Crisis PRNewswire 7:00 AM

-- February 12, 2024 --

Alexandria Real Estate Equities, Inc. Announces Long-Term Tenant AstraZeneca Is Investing $300 Million in a Next-Generation Cell Therapy Manufacturing Facility at the Alexandria Center for Life Science - Shady Grove Mega Campus in Rockville, Maryland PRNewswire 8:30 AM

-- February 1, 2024 --

Alexandria Real Estate Equities, Inc. Announces Pricing of Public Offering of $400,000,000 of Senior Notes due 2036 $600,000,000 of Senior Notes due 2054 PRNewswire 6:42 PM
Alexandria Real Estate Equities, Inc. Announces Public Offering of Senior Notes PRNewswire 8:50 AM

-- January 29, 2024 --

Alexandria Real Estate Equities, Inc. Reports: 4Q23 Net Loss per Share - Diluted of $0.54; 2023 Net Income per Share - Diluted of $0.54; and 4Q23 and 2023 FFO per Share - Diluted, As Adjusted, of $2.28 and $8.97, respectively PRNewswire 4:10 PM

-- January 26, 2024 --

Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2023 Distributions PRNewswire 8:30 AM

-- January 5, 2024 --

Alexandria Real Estate Equities, Inc. Celebrates 30 Years at the Vanguard and Heart of the $5 Trillion Secularly Growing Life Science Industry PRNewswire 8:30 AM

-- December 15, 2023 --

Alexandria Real Estate Equities, Inc. Announces Long-Term 165,940 RSF, Full-Building Lease With Novo Nordisk for R&D Center at the Alexandria Center for Life Science - Waltham Mega Campus in Greater Boston PRNewswire 8:30 AM

-- December 14, 2023 --

Alexandria Real Estate Equities, Inc. Announces Long-Term 99,557 RSF Lease With CARGO Therapeutics for Its New Headquarters and R&D Center at the Alexandria Center for Life Science - San Carlos Mega Campus in the San Francisco Bay Area PRNewswire 8:30 AM

-- December 4, 2023 --

Alexandria Real Estate Equities, Inc. Elects Sheila McGrath to Board of Directors PRNewswire 4:10 PM
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.27 per Common Share for 4Q23, an Increase of 3 Cents Over 3Q23, and an Aggregate of $4.96 per Common Share for 2023, an Increase of 24 Cents, or 5 Percent, Over 2022 PRNewswire 8:30 AM

-- November 30, 2023 --

Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2023 Operating and Financial Results Conference Call and Webcast on January 30, 2024 PRNewswire 8:30 AM